WebMay 23, 2024 · Plaintiffs sought damages for what they claimed was AXIS's breach, under the relevant policy, of its duty to defend them in connection with an investigation conducted by the Securities and Exchange Commission against BioChemics and its officers. WebSep 6, 2024 · In Biochemics, Inc. v. AXIS Reinsurance Company, 2024 WL 2223125 (1st Cir. 2024), the SEC issued a subpoena to Biochemics on May 5, 2011, requesting that Biochemics produce certain documentation in connection with the SEC’s investigation into whether Biochemics and its President and CEO, John Masiz, had committed securities …
Biochemics, Inc. v. Axis Reinsurance Co. - casetext.com
WebJun 24, 2024 · In BioChemics, Inc. v. AXIS Reinsurance Co., 2024 WL 2223125 (1st Cir. May 23, 2024), the United States Court of Appeals for the First Circuit held that a D&O policy did not provide coverage for an SEC … WebBiochemistry or biological chemistry is the study of chemical processes within and relating to living organisms. A sub-discipline of both chemistry and biology, biochemistry may be divided into three fields: structural … how many gears does an 18 wheeler truck have
Biopharma Firm Took $9 Million, SEC Says - Courthouse …
WebDec 16, 2012 · Three repeat securities law violators teamed up to defraud 70 investors of over $9 million over three years. The complaint claims the defendants sold interests in a privately held biochemical company based on a series of misrepresentations. SEC v. Biochemics, Inc., Civil Action No. 1:12-cv-12324 (D. Mass. Filed Dec. 14, 2012). Web•the SEC served deposition subpoenas on Masiz and two other individuals in January 2012 (during the policy period); • the SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and • the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December … houti scrabble